The effect of modest salt reduction on blood pressure and endothelial function in diabetic patients

ISRCTN ISRCTN41450337
DOI https://doi.org/10.1186/ISRCTN41450337
Secondary identifying numbers N0236194367
Submission date
23/04/2008
Registration date
23/01/2009
Last edited
19/07/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Rebecca Suckling
Scientific

Blood Pressure Unit
St George's University of London
Cranmer Terrace
Tooting
London
SW17 0RE
United Kingdom

Email rsuckling@sgul.ac.uk

Study information

Study designRandomised cross-over study
Primary study designInterventional
Secondary study designRandomised cross over trial
Study setting(s)Other
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleThe effect of modest salt reduction on blood pressure and endothelial function in diabetic patients: a randomised cross-over study
Study objectivesWe propose that a moderate reduction in salt intake will improve blood pressure, endothelial function and damage to target organs without affecting insulin sensitivity.
Ethics approval(s)Wandsworth Local Research Ethics Committee, 08/06/2006, ref: 06/Q0803/45
Health condition(s) or problem(s) studiedCardiovascular disease
InterventionIndividuals will have an initial two-week run-in period where dietary salt advice is given to achieve a salt reduction of 6 g. They are then randomised by computer-generated random allocation to either placebo or salt 6 g daily for six weeks in matched tablets. Both the study participants and the investigators are blinded. There is no washout period. At the end of the study, individuals are seen at 2 - 4 weeks for a follow up visit.
Intervention typeOther
Primary outcome measureCasual systolic and diastolic blood pressure. Primary outcomes are measured at baseline and weeks 2, 5, 8, 11 and 14.
Secondary outcome measures1. Urinary albumin excretion
2. Ambulatory blood pressure monitoring (ABPM)
3. Endothelial function
4. Arterial stiffness

Secondary outcomes are measured at baseline and weeks 8 and 14.
Overall study start date01/10/2006
Completion date01/10/2008

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants50
Key inclusion criteria1. Age 30 to 80 years, either sex
2. Untreated blood pressure of greater than 120/70 mmHg with impaired glucose tolerance on oral glucose tolerance test or diet controlled type two diabetes
Key exclusion criteria1. Uncontrolled hypertension (blood pressure greater than 160/100 mmHg)
2. Type two diabetes on oral hypoglycaemic agents or insulin
3. Secondary hypertension
4. Uncontrolled heart failure or active ischaemic heart disease
5. Active malignancy or liver disease
6. Females who are pregnant, breast feeding or taking the oral contraceptive pill
7. Individuals started on lipid lowering therapy within the last three months
Date of first enrolment01/10/2006
Date of final enrolment01/10/2008

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

St George's University of London
London
SW17 0RE
United Kingdom

Sponsor information

St George's University of London (UK)
Hospital/treatment centre

Cranmer Terrace
Tooting
London
SW17 0RE
England
United Kingdom

Email sallen@sgul.ac.uk
Website http://www.sgul.ac.uk/
ROR logo "ROR" https://ror.org/040f08y74

Funders

Funder type

Charity

NHS R & D Support Funding (UK)

No information available

Hypertension Trust (UK)
Private sector organisation / Other non-profit organizations
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

19/07/2017: No publications found in PubMed, verifying study status with principal investigator.